Stockreport

Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference

Pliant Therapeutics, Inc.  (PLRX) 
PDF SOUTH SAN FRANCISCO, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company and leader in the discov [Read more]